At a glance
ClinicalIndex Comparison RecordN/ACompleted· 288 enrolled
Drug / intervention
AHCL insulin pump systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects
In Brief
A clinical study evaluating AHCL insulin pump system for Type 1 Diabetes Mellitus. Completed, enrolled 288 participants across 17 sites.
Detailed Summary
This study is a Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes Mellitus
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedMay 2019
Enrollment StartJul 2019
Primary CompletionMar 2021
Study CompletionOct 2023
TodayJul 2026
First PostedMay 22, 2019
Enrollment StartJul 24, 2019
Primary CompletionMar 17, 2021
Study CompletionOct 27, 2023
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 7.1 years ago
Interventions
AHCL insulin pump systemdevice
670G 4.0 system with GS3; 780G system with G4S (continued access phase);